Navigation Links
The Pulmonary Hypertension Association and MedicAlert Foundation Form Alliance to Safeguard Patients

SILVER SPRING, Md., July 28, 2011 /PRNewswire-USNewswire/ -- Furthering their efforts to provide support to pulmonary hypertension (PH) patients, the Pulmonary Hypertension Association (PHA) has entered into a partnership with MedicAlert Foundation that will offer PHA members a discount on MedicAlert membership. By joining MedicAlert, PHA members will benefit from MedicAlert's unique, live 24/7 emergency response/family notification services should an emergency arise. Additionally, PHA members who join MedicAlert will have the ability to store and manage an online Emergency Medical Information Record (EMIR), which allows them to maintain updated health information, medications, test results, and physician contacts. The MedicAlert EMIR has been designed in conjunction with the American College of Emergency Physicians to contain the critical information needed by first responders and hospital emergency departments. MedicAlert membership provides medical and emergency response staff with swift access to patients' key health information, enabling them to quickly recognize patients with pulmonary hypertension and administer proper treatment.

"PH is a life-threatening illness in which the vessels in the lungs thicken and constrict, leading to heart failure," says Rino Aldrighetti, President and CEO of the Pulmonary Hypertension Association. "Because the disease is not commonly seen by most medical professionals, a MedicAlert medical ID can lead to quick understanding and appropriate response in an emergency situation."

Pulmonary hypertension treatments are complex and difficult. In some cases, standard emergency medical procedures may be life-threatening to PH patients. Proactive education of emergency responders and medical staff, coupled with MedicAlert's live 24/7 identification and information services, helps to ensure that PH patients will receive the care they need in an emergency situation.

"We are proud to be working alongside the Pulmonary Hypertension Association in the effort to educate and advocate on behalf of the pulmonary hypertension community," said Andrew B. Wigglesworth, President & CEO of MedicAlert Foundation. "MedicAlert services provide critical support for individuals with complex illnesses like PH by relaying vital medical information in an emergency. Our proven capability to speak on behalf of our members during medical emergencies has positioned MedicAlert as the leading communication service for the PH patient community."

For more information about the Pulmonary Hypertension Association and MedicAlert Foundation's special offer, visit  

About MedicAlert Foundation

Established in 1956, MedicAlert Foundation pioneered the use of medical IDs and systems to relay vital medical information to emergency responders on behalf of its members so they receive faster and safer treatment. Today, MedicAlert provides the functionality of an e-health information exchange through an innovative combination of a unique patient identifier linked to an emergency medical information record and a live 24/7 emergency response service. MedicAlert medical IDs alert emergency personnel to a member's primary health conditions, medications, and/or implanted medical devices. In addition to its live 24/7 emergency response service, MedicAlert Foundation also provides family and caregiver notification so that members can be reunited with their loved ones. MedicAlert services are available around the world through a network of international nonprofit affiliated organizations licensed by the Foundation. Learn more at

About The Pulmonary Hypertension Association (PHA)

Headquartered in Silver Spring, Maryland, PHA is the country's leading organization connecting pulmonary hypertension patients, families, and medical professionals. Its mission is to find ways to prevent and cure pulmonary hypertension and provide hope for the community through support, education, advocacy, and awareness. PHA provides free access to information on its website about pulmonary hypertension and facilitates over 200 support groups around the nation, helping many of the estimated 30,000 diagnosed patients in the United States. To learn more, visit

SOURCE MedicAlert Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
2. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
3. Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease
4. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
5. Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
6. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
7. Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
8. Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
9. APTA Supports Surgeon Generals Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
10. Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
11. Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
Post Your Comments:
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... November 28, 2015 , ... ... and teleradiology services, has added Chris Hafey and Claude Hooton to its board ... Radiological Society of North America (RSNA) 2015 Annual Meeting and continues to strategically ...
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch can ... "I conceived of this design due to personal experience with a bad back," he ... relaxation and convenience, as well as increases support. It also makes it easier to ...
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back again with ... the possibilities are endless. Users have full control over angle of view, speed method, ... users are sure to get heads to turn. , ProPanel: Pulse offers fully customizable ...
(Date:11/27/2015)... ... 27, 2015 , ... According to an article published November 13th ... in Washington D.C. revolved around the fact that proper dental care, both at-home and ... the link between periodontal disease (more commonly referred to as gum disease) and diabetes. ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
Breaking Medicine News(10 mins):